Home

Glenmark Pharmaceuticals PE Ratio

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

PE

32.4

Last updated on: Jun 04, 2025

Key Highlights

  • The P/E Ratio of Glenmark Pharmaceuticals Ltd is 32.4 as of 04 Jun 15:30 PM .
  • The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 1515 as of 04 Jun 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 8.8. The PE Ratio of Finance industry is 14.5. The PE Ratio of IT - Software industry is 25.8. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 9.8 in 2025.

Historical P/E Ratio of Glenmark Pharmaceuticals Ltd

No data available

Company Fundamentals for Glenmark Pharmaceuticals Ltd

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

Share Price

₹ 1515.15

1.50 (0.10%)

stock direction

Last updated on: Jun 04, 2025

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Jun 20251515.15
03 Jun 20251513.65
02 Jun 20251496.85
30 May 20251457.75
29 May 20251396.55
28 May 20251379.4
27 May 20251384.05
26 May 20251389.2
23 May 20251418.6
22 May 20251431.1

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

che

Weakness

2

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Glenmark Pharmaceuticals Ltd

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Glenmark Pharmaceuticals Ltd42757
Sun Pharmaceutical Industries Ltd399549
Divis Laboratories Ltd175673
Cipla Ltd118901
Torrent Pharmaceuticals Ltd106101
Dr Reddys Laboratories Ltd104486

PE Ratio of Glenmark Pharmaceuticals Ltd Explained

42757

Market cap

1047

Earnings

32.4X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Glenmark Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Glenmark Pharmaceuticals Ltd

No data available

* All values are in %

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.
  • The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.

Glenmark Pharmaceuticals Ltd News Hub

Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session

Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1

Read more

21 Aug 24

Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163

Read more

19 Aug 24

Glenmark Pharma gains after American subsidiary launches Olopatadine generic

The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L

Read more

19 Aug 24

Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio

Read more

19 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Glenmark Pharmaceuticals Ltd

What is the current PE Ratio of Glenmark Pharmaceuticals Ltd?

The Current PE Ratio of Glenmark Pharmaceuticals Ltd is 32.44 as on 4 Jun 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 35.4 as on 4 Jun 2025.

What was the PE Ratio of Glenmark Pharmaceuticals Ltd last year?

The PE Ratio of Glenmark Pharmaceuticals Ltd was 44.16 last year, now the PE ratio is 32.44, showing a year-on-year growth of -26.5%.

What does the PE Ratio of Glenmark Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Glenmark Pharmaceuticals Ltd is 32.44. This ratio indicates that investors are willing to pay 32.44 times the earnings per share for each share of Glenmark Pharmaceuticals Ltd.

What is the PE Ratio Growth of Glenmark Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Glenmark Pharmaceuticals Ltd grew by -26.5% whereas, the EPS ratio grew by -98.7.

How does the PE ratio of Glenmark Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Glenmark Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Glenmark Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Glenmark Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Glenmark Pharmaceuticals Ltd PE Ratio?

The PE ratio of Glenmark Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Glenmark Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Glenmark Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Glenmark Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Glenmark Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Glenmark Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Glenmark Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Glenmark Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Glenmark Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions